Announcements Trials
Browse Landscape

Phase

Phase 2 205Phase 3 109Phase 1 52Phase 1/2 48Phase 2/3 11Phase NA 5Phase 4 5Phase EARLY_PHASE1 1

Status

Unknown 2Completed 2Terminated 1

Sponsor Class

OTHER 2OTHER_GOV 1NETWORK 1INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 5

Conditions

Breast Neoplasms 16Carcinoma, Non-Small-Cell Lung 5Lung Neoplasms 2Head and Neck Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Neoplasms, Second Primary 1NSCLC 1Locally Advanced Breast Cancer 1Carcinoma, Squamous Cell 1Adenocarcinoma 1

Interventions

Pemetrexed 10Cisplatin 9Erlotinib Hydrochloride 8Carboplatin 7icotinib 5Gefitinib 5Docetaxel 5endostar protein 3Zoledronic Acid 3Radiotherapy 3Paclitaxel 3Gemcitabine 3Endostatins 3Afatinib 3tislelizumab 2pembrolizumab 2osimertinib 2lorlatinib 2flurbiprofen axetil 2dexamethasone 21-phosphate 2atezolizumab 2Vinorelbine 2Surgical Procedures, Operative 2Saline Solution 2Nivolumab 2Drug Therapy 2Dexamethasone 2Chemoradiotherapy 2trametinib 1spartalizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 4 × Carcinoma, Non-Small-Cell Lung × Docetaxel × Clear all
NCT02031601 2016-03-29

TCL-1

Qilu Hospital of Shandong University

Phase 4 Unknown
250 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00883675 2013-12-18

Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer

Maestro Clinical, Inc.

Phase 4 Completed
133 enrolled 8 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00536107 2013-10-01

Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

AstraZeneca

Phase 4 Terminated
14 enrolled 12 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01442909 2011-09-29

Pemetrexed Followed by Docetaxel or in Reverse Sequence

Taipei Veterans General Hospital, Taiwan

Phase 4 Completed
44 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00813332 2010-01-25

Second-line Therapy Study of Combined Chemotherapy and Endostar to Patients With Non-Small Cell Lung Cancer(NSCLC)

Simcere Pharmaceutical Co., Ltd

Phase 4 Unknown
300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡